Iridex Corp. (IRIX)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS

1212 TERRA BELLA AVE MOUNTAIN VIEW, CA 94043

Iridex Corporation is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. The Company's proprietary MicroPulse® technology delivers a differentiated treatment that provides safe, effective, and proven treatment for targeted sight-threatening eye conditions. Iridex's current product line is used for the treatment of glaucoma and diabetic macular edema (DME) and other retinal diseases. Iridex products are sold in the United States through a direct sales force and internationally primarily through a network of independent distributors into more than 100 countries.

Data as of 2021-06-19 11:29:23 -0400
Market Cap109.381 Million Shares Outstanding15.626 Million Avg 30-day Volume56.794 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-12.73 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.0 52-week High/Low9.71 / 1.6 Next Earnings Date2021-08-05 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from IRIX instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 1 1 0.0% 0 (0.0%) 0 (0.0%)
Funds Holding: 29 23 26.09% 11 (0.65%) 6 (0.35%) 83.33%
13F shares: 3.835 Million 4.126 Million -7.06% 1.183 Million 1.464 Million -19.21%
% Ownership 24.7073 29.6888 -16.78% 7.6222 10.5372 -27.66%
New Positions: 11 2 450.0% 5
Increased Positions 6 7 -14.29% 2 2 0.0%
Closed Positions 4 5 -20.0% 3
Reduced Positions 8 6 33.33% 3 2 50.0%
Total Calls 2 125 -98.4%
Total Puts 11.507 Thousand 125 9105.6%
PUT/CALL Ratio 5,753.5 1.0 575250.0% 575250.0%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding IRIX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding IRIX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SHUDA SCOTT

  • Director
41,327 2021-06-16 1

GROVE ROBERT EARLE

  • Director
91,720 2021-06-16 1

LUDLUM KEN

  • Director
34,972 2021-06-16 1

DEVI NANDINI

  • Director
0 2021-06-16 2

MERCER PATRICK COO

  • Officer
33,912 2021-05-30 13

TOPCON AMERICA CORP

TOPCON CORP

  • 10% Owner
1,618,122 2021-03-10 1

AHMAD FUAD INTERIM CFO

  • Officer
0 2020-11-11 1

BRUCE DAVID PRESIDENT AND CEO

  • Officer
  • Director
74,979 2020-09-03 2

GUNST ROBERT A

  • Director
50,568 2020-06-24 0

ENGIBOUS DORIS

  • Director
18,348 2020-06-24 0

DIZON ROMEO R

  • VICE PRESIDENT - FINANCE
36,263 2019-10-22 0

NAUMANN-ETIENNE RUEDIGER

  • Director
109,872 2019-07-23 0

SAINZ MARIA

  • Director
16,894 2019-07-23 0

MOORE WILLIAM M CHAIRMAN AND CEO

  • Officer
  • Director
522,975 2019-04-24 0

MOKARI ATABAK CFO AND VP CORP DEVELOPMENT

  • Officer
81,787 2018-11-24 0

PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE

PARAGON JV PARTNERS, LLC

DYER BRADBURY III

  • FORMER 10% SHAREHOLDERFORMER 10% SHAREHOLDERFORMER 10% SHAREHOLDER
No longer subject to file 2018-09-18 0

FITCH SANFORD

  • Director
62,887 2018-06-13 0

RHOADS ANN D

  • Director
5,690 2018-06-13 0

BLUELINE CAPITAL PARTNERS, L.P.

BLUELINE CAPITAL PARTNERS II, L.P.

BLUELINE CAPITAL PARTNERS III, LP

BLUELINE PARTNERS, L.L.C.

BLUELINE PARTNERS II, LLC

BLUELINE CATALYST FUND IX, L.P.

  • 10% Owner
1,138,862 2017-11-21 0

MARCELLINO GEORGE R

  • Director
30,590 2017-10-25 0

ACUTA CAPITAL FUND, LP

  • 10% Owner
1,344,720 2017-07-03 0

STECKEL RONALD VP, OPERATIONS

  • Officer
65,625 2016-06-06 0

MACKANESS JAMES H CFO AND COO

  • Officer
45,052 2015-08-19 0

BLUELINE CAPITAL PARTNERS, L.P.

BLUELINE CATALYST FUND IX, L.P.

BLUELINE CAPITAL PARTNERS II, L.P.

BLUELINE CAPITAL PARTNERS III, LP

BLUELINE PARTNERS, L.L.C.

BLUELINE PARTNERS II, LLC

MERIDIAN OHC PARTNERS, LP

TSV INVESTMENT PARTNERS, LLC

  • Director
  • 10% Owner
2,280,523 2015-06-03 0

HAWKINS JAMES B

  • Director
31,294 2014-08-22 0

GARRETTSON GARRETT A

  • Director
39,441 2014-08-11 0

ARIAS EDUARDO SR. VP, GLOBAL SALES

  • Officer
0 2013-06-18 0

ANDERSON ROBERT K CHAIRMAN AND CEO

  • Officer
  • Director
129,340 2012-09-12 0

BLUELINE CATALYST FUND IX, L.P.

BLUELINE CAPITAL PARTNERS, L.P.

BLUELINE PARTNERS II, LLC

BLUELINE CAPITAL PARTNERS III, LP

BLUELINE PARTNERS, L.L.C.

  • 10% Owner
2,605,536 2012-08-10 0

BECK DOMINIK PRESIDENT AND CEO

  • Officer
  • Director
75,000 2011-10-10 0

BOUTACOFF THEODORE A PRESIDENT, CEO AND CHAIRMAN

  • Officer
  • Director
0 2010-04-29 0

BLUELINE PARTNERS, L.L.C.

BLUELINE CAPITAL PARTNERS, L.P.

BLUELINE PARTNERS II, LLC

BLUELINE CAPITAL PARTNERS III, LP

BLUELINE CATALYST FUND VIII, L.P.

BLUELINE CATALYST FUND IX, L.P.

  • 10% Owner
2,483,815 2009-12-05 0

POWERS TIMOTHY S VP, OPERATIONS

  • Officer
0 2009-09-03 0

BLUELINE PARTNERS, L.L.C.

BLUELINE CAPITAL PARTNERS, L.P.

BLUELINE CAPITAL PARTNERS II, L.P.

BLUELINE CAPITAL PARTNERS III, LP

BLUELINE CATALYST FUND VIII, L.P.

BLUELINE CATALYST FUND IX, L.P.

BLUELINE PARTNERS II, LLC

  • 10% Owner
2,465,222 2009-07-02 0

BLUELINE PARTNERS, L.L.C.

BLUELINE CAPITAL PARTNERS, L.P.

BLUELINE PARTNERS II, LLC

BLUELINE CAPITAL PARTNERS III, LP

BLUELINE CATALYST FUND VIII, L.P.

  • 10% Owner
2,444,322 2009-02-04 0

HAMMOND DONALD L

  • Director
0 2008-07-01 0

TODD DONALD J VP OF MARKETING

  • Officer
0 2008-02-13 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

GROVE ROBERT EARLE - Director

2021-06-21 19:27:38 -0400 2021-06-16 A 5,420 a 91,720 direct 1.0495 1.0495 2 0.0 1

DEVI NANDINI - Director

2021-06-21 18:56:22 -0400 2021-06-16 A 5,420 a 5,420 direct 1.0495 1.0495 2 0.0 1

SHUDA SCOTT - Director

2021-06-21 19:17:47 -0400 2021-06-16 A 6,775 a 41,327 direct 1.0495 1.0495 2 0.0 1

LUDLUM KEN - Director

2021-06-21 19:30:22 -0400 2021-06-16 A 5,420 a 34,972 direct 1.0495 1.0495 2 0.0 1

DEVI NANDINI - Director

2021-06-21 18:56:22 -0400 2021-06-16 A 15,000 a 15,000 direct

MERCER PATRICK - Officer COO

2021-06-01 17:36:34 -0400 2021-05-30 F 70 $7.86 d 33,912 direct -3.0418 -2.7883 0.0 1 -6.4639 4

MERCER PATRICK - Officer COO

2021-05-03 17:21:19 -0400 2021-04-30 F 70 $8.60 d 33,981 direct -3.8366 -10.396 -8.6634 0.0 1 -10.7673 8

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
IRIDEX CORP IRIX 2021-06-24 15:15:03 UTC -0.2738 0.3538 400000
IRIDEX CORP IRIX 2021-06-24 14:45:03 UTC -0.2128 0.2928 400000
IRIDEX CORP IRIX 2021-06-24 14:15:02 UTC -0.2128 0.2928 400000
IRIDEX CORP IRIX 2021-06-24 13:45:03 UTC -0.2128 0.2928 400000
IRIDEX CORP IRIX 2021-06-24 13:15:02 UTC -0.2128 0.2928 400000
IRIDEX CORP IRIX 2021-06-24 12:45:03 UTC -0.2128 0.2928 400000
IRIDEX CORP IRIX 2021-06-23 22:15:03 UTC -0.2128 0.2928 450000
IRIDEX CORP IRIX 2021-06-23 21:45:03 UTC -0.2128 0.2928 450000
IRIDEX CORP IRIX 2021-06-23 21:15:03 UTC -0.2128 0.2928 450000
IRIDEX CORP IRIX 2021-06-23 20:45:02 UTC -0.2128 0.2928 450000
IRIDEX CORP IRIX 2021-06-23 20:15:04 UTC -0.2128 0.2928 450000
IRIDEX CORP IRIX 2021-06-23 19:45:03 UTC -0.2128 0.2928 450000
IRIDEX CORP IRIX 2021-06-23 19:15:03 UTC -0.2128 0.2928 450000
IRIDEX CORP IRIX 2021-06-23 18:45:02 UTC -0.2128 0.2928 450000
IRIDEX CORP IRIX 2021-06-23 18:15:03 UTC -0.2128 0.2928 450000
IRIDEX CORP IRIX 2021-06-23 17:45:02 UTC -0.2128 0.2928 450000
IRIDEX CORP IRIX 2021-06-23 17:15:03 UTC -0.2128 0.2928 450000
IRIDEX CORP IRIX 2021-06-23 16:45:03 UTC -0.2128 0.2928 450000
IRIDEX CORP IRIX 2021-06-23 16:15:03 UTC -0.2128 0.2928 450000
IRIDEX CORP IRIX 2021-06-23 15:45:03 UTC -0.2128 0.2928 450000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments